Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04839679
Other study ID # 20-005385
Secondary ID NCI-2021-13435
Status Recruiting
Phase N/A
First received
Last updated
Start date March 30, 2021
Est. completion date April 1, 2025

Study information

Verified date April 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research study is being done in order to better understand and identify American Indian/Alaskan Native (AI/AN) cancer patients' attitudes and beliefs towards radiation therapy treatment plans and their willingness to pursue them.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date April 1, 2025
Est. primary completion date April 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient at least 18 years of age with cancer diagnosis. - Radiation therapy is recommended for their cancer treatment as a next step in their cancer care. - Cognitive capacity to complete a paper-and-pencil survey. - Ability to communicate and understand English with proficiency to provide informed consent and complete a paper-and-pencil survey. Exclusion Criteria: - Patient < 18 years of age. - Patient does not have a cancer diagnosis.

Study Design


Related Conditions & MeSH terms

  • Neoplasms
  • Patient Education in Radiation Oncology

Intervention

Behavioral:
Culturally Oriented Educational Brochure
Culturally appropriate educational brochure summarizing pertinent treatment information in a visual manner
Mayo Clinic Educational Booklet
"An Introduction to Radiation Simulation and Treatment"- Barbara Woodward Lips, Patient Education Center

Locations

Country Name City State
United States Mayo Clinic in Arizona Phoenix Arizona

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in patient anxiety Measured using self-reported Hospital Anxiety and Depression Scale (HADS) Survey to ascertain any anxiety and/or depression that they may be experiencing with respect to their diagnosis and treatment. Questionnaire total score reported on a scale of 0-7 = normal, 8-10 borderline abnormal (borderline case), 11-21 abnormal (case) Baseline, day 14
Primary Radiotherapy completion rates in the AI/AN community Number of participates to complete radiation therapy as prescribed 90 days
Primary Change in patient perception of information received Measured by the EORTC QLQ - INFO25 survey, which is a validated instrument that will gauge their satisfaction with the information they received regarding their diagnosis and treatment plan. Questionnaire of 24 questions regarding information received during treatment using a scale of 1 (not at all) to 4 (very much). Baseline, day 14